Pelvic Arterial Occlusive Disease Affects the RhoA/Rho-Kinase Pathway in Bladder Smooth Muscle-Reference-Cited by-同舟云学术

Pelvic Arterial Occlusive Disease Affects the RhoA/Rho-Kinase Pathway in Bladder Smooth Muscle

Published:2015-02 Issue:2 Volume:193 Page:706-713
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Akaihata Hidenori¹,Nomiya Masanori¹,Hata Junya¹,Yabe Michihiro¹,Takahashi Norio¹,Haga Nobuhiro¹,Kushida Nobuhiro¹,Ishibashi Kei¹,Aikawa Ken¹,Yamaguchi Osamu¹,Kojima Yoshiyuki¹

Affiliation:

1. Department of Urology, Fukushima Medical University School of Medicine, Fukushima and Division of Bioengineering and LUTD Research, Nihon University School of Engineering (MN, OY), Koriyama, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

2. Place of overactive bladder in male lower urinary tract symptoms;Yamaguchi;World J Urol,2009

3. Storage and voiding symptoms: pathophysiologic aspects;Andersson;Urology,2003

4. The association between vascular risk factors and lower urinary tract symptoms in both sexes;Ponholzer;Eur Urol,2006

5. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography;Pinggera;BJU Int,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3 is involved in inflammation and fibrosis in arteriogenic erectile dysfunction via the TLR4/MyD88/NF-κB pathway;Cell Death Discovery;2024-02-20

2. Mechanism of Galectin-3 in arteriogenic erectile dysfunction via TLR4/MyD88/NF-κB pathway;2023-09-20

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat;International Journal of Molecular Sciences;2023-02-16

5. Tetrahydrobiopterin prevents chronic ischemia-related lower urinary tract dysfunction through the maintenance of nitric oxide bioavailability;Scientific Reports;2020-11-16